UNLABELLED: CD8(+) T cells represent a sizable component of the liver inflammatory infiltrate in chronic hepatitis C and are thought to contribute to immune-mediated tissue injury. Because chronic stimulation may promote the expression by CD8(+) T cells of distinct human leukocyte antigen class I-specific natural killer cell receptors (NKRs) susceptible to both inhibiting effector functions and promoting cell survival, we examined the distribution and characteristics of CD8(+) T cells with such receptors in chronic hepatitis C patients. NKR CD8(+) T cells were detectable in liver and peripheral blood from hepatitis C virus (HCV)-infected patients but were not major subsets. However, the frequency of NKG2A(+) CD8(+) in the liver and in a lesser extent in the peripheral blood was positively correlated to histological activity in HCV-infected patients. No such correlation was found with KIR(+) T cells in liver in HCV-infected patients and with the both NKR CD8(+) T cells in hepatitis B virus (HBV) infected patients. Circulating CD8(+) T cells expressing KIRs exhibited phenotypic features of memory T cells with exacerbated expression of the senescence marker CD57 in patients. NKG2A(+)CD8(+) T cells were committed T cells that appeared less differentiated than KIR(+)CD8(+) T cells. In HCV-infected patients, their content in perforin was low and similar to that observed in NKG2A(-)CD8(+) T cells; this scenario was not observed in healthy subjects and HBV-infected patients. Both NKG2A and KIRs could inhibit the response of HCV-specific CD8(+) T cells ex vivo. CONCLUSION: These results support the concept that an accumulation in the liver parenchyma of NKR(+)CD8(+) T cells that have functional alterations could be responsible for liver lesions. They provide novel insights into the complexity of liver-infiltrating CD8(+) T cells in chronic hepatitis C and reveal that distinct subsets of antigen-experienced CD8(+) T cells are differentially sensitive to the pervasive influence of HCV.
UNLABELLED: CD8(+) T cells represent a sizable component of the liver inflammatory infiltrate in chronic hepatitis C and are thought to contribute to immune-mediated tissue injury. Because chronic stimulation may promote the expression by CD8(+) T cells of distinct human leukocyte antigen class I-specific natural killer cell receptors (NKRs) susceptible to both inhibiting effector functions and promoting cell survival, we examined the distribution and characteristics of CD8(+) T cells with such receptors in chronic hepatitis Cpatients. NKR CD8(+) T cells were detectable in liver and peripheral blood from hepatitis C virus (HCV)-infectedpatients but were not major subsets. However, the frequency of NKG2A(+) CD8(+) in the liver and in a lesser extent in the peripheral blood was positively correlated to histological activity in HCV-infectedpatients. No such correlation was found with KIR(+) T cells in liver in HCV-infectedpatients and with the both NKR CD8(+) T cells in hepatitis B virus (HBV) infectedpatients. Circulating CD8(+) T cells expressing KIRs exhibited phenotypic features of memory T cells with exacerbated expression of the senescence marker CD57 in patients. NKG2A(+)CD8(+) T cells were committed T cells that appeared less differentiated than KIR(+)CD8(+) T cells. In HCV-infectedpatients, their content in perforin was low and similar to that observed in NKG2A(-)CD8(+) T cells; this scenario was not observed in healthy subjects and HBV-infectedpatients. Both NKG2A and KIRs could inhibit the response of HCV-specific CD8(+) T cells ex vivo. CONCLUSION: These results support the concept that an accumulation in the liver parenchyma of NKR(+)CD8(+) T cells that have functional alterations could be responsible for liver lesions. They provide novel insights into the complexity of liver-infiltrating CD8(+) T cells in chronic hepatitis C and reveal that distinct subsets of antigen-experienced CD8(+) T cells are differentially sensitive to the pervasive influence of HCV.
Authors: Niklas K Björkström; Vivien Béziat; Frank Cichocki; Lisa L Liu; Jeffrey Levine; Stella Larsson; Richard A Koup; Stephen K Anderson; Hans-Gustaf Ljunggren; Karl-Johan Malmberg Journal: Blood Date: 2012-09-11 Impact factor: 22.113
Authors: Susanne Knapp; Usama Warshow; Doha Hegazy; Louise Brackenbury; I Neil Guha; Andrew Fowell; Ann-Margaret Little; Graeme J Alexander; William M C Rosenberg; Matthew E Cramp; Salim I Khakoo Journal: Hepatology Date: 2010-04 Impact factor: 17.425
Authors: S Russi; G Lauletta; G Serviddio; S Sansonno; V Conteduca; L Sansonno; V De Re; D Sansonno Journal: Clin Exp Immunol Date: 2013-05 Impact factor: 4.330
Authors: Arnaud D Colantonio; Benjamin N Bimber; William J Neidermyer; R Keith Reeves; Galit Alter; Marcus Altfeld; R Paul Johnson; Mary Carrington; David H O'Connor; David T Evans Journal: PLoS Pathog Date: 2011-03-10 Impact factor: 6.823